Toronto, Canada · Founded 2023 · Privately Held (backing)
Developer of an artificial intelligence drug discovery platform designed to offer targeted therapies for biologically defined patient sub-populations. Biossil is based in Toronto, Canada and was founded in 2023. It has raised $12.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.4M
Last round
—
Team — not yet on record
No current team members for Biossil are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biossil with a free account
·Watch Biossil: the Monday email on marks, rounds and moves
